Buckle up, CG Oncology (NASDAQ: CGON) investors, because things are about to get bumpy...in the best way possible! Today, Wall...
bladder cancer
Seeking hope for bladder cancer patients? Investigate CG Oncology’s (CGON) innovative gene therapy in clinical trials.
Bladder cancer is a nasty foe, often requiring multiple rounds of grueling treatments with limited success. But buckle up, folks,...
